Peter Bläuenstein

1.8k total citations
52 papers, 1.5k citations indexed

About

Peter Bläuenstein is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Epidemiology. According to data from OpenAlex, Peter Bläuenstein has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Peter Bläuenstein's work include Radiopharmaceutical Chemistry and Applications (35 papers), Peptidase Inhibition and Analysis (12 papers) and Neuroendocrine Tumor Research Advances (11 papers). Peter Bläuenstein is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (35 papers), Peptidase Inhibition and Analysis (12 papers) and Neuroendocrine Tumor Research Advances (11 papers). Peter Bläuenstein collaborates with scholars based in Switzerland, Belgium and Germany. Peter Bläuenstein's co-authors include P. August Schubiger, Dirk Tourwé, Elisa García‐Garayoa, Véronique Maes, Elisa Garcı́a Garayoa, Alain Blanc, Roger Schibli, Annette G. Beck‐Sickinger, G. Anderegg and Ilse Novak‐Hofer and has published in prestigious journals such as Clinical Cancer Research, Journal of Medicinal Chemistry and American Heart Journal.

In The Last Decade

Peter Bläuenstein

52 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bläuenstein Switzerland 24 951 646 341 311 310 52 1.5k
Gary L. Sieckman United States 24 1.3k 1.3× 837 1.3× 344 1.0× 341 1.1× 230 0.7× 42 1.7k
Karen E. Linder United States 18 739 0.8× 346 0.5× 257 0.8× 169 0.5× 177 0.6× 34 1.2k
Luigi Aloj Italy 27 1.1k 1.1× 867 1.3× 590 1.7× 338 1.1× 204 0.7× 106 2.4k
Adrian D. Nunn United States 27 1.3k 1.4× 492 0.8× 510 1.5× 221 0.7× 202 0.7× 93 2.4k
Charles J. Smith United States 29 1.1k 1.1× 793 1.2× 634 1.9× 280 0.9× 208 0.7× 73 2.5k
Anastasia Nikolopoulou United States 24 1.4k 1.5× 892 1.4× 302 0.9× 449 1.4× 309 1.0× 52 2.0k
Frank Roesch Germany 25 1.5k 1.6× 993 1.5× 249 0.7× 251 0.8× 187 0.6× 104 2.2k
Alexandra D. Varvarigou Greece 19 733 0.8× 371 0.6× 214 0.6× 162 0.5× 110 0.4× 70 1.1k
Tammy L. Rold United States 20 875 0.9× 585 0.9× 263 0.8× 193 0.6× 140 0.5× 34 1.2k
Peter Roselt Australia 25 980 1.0× 541 0.8× 362 1.1× 169 0.5× 83 0.3× 71 1.7k

Countries citing papers authored by Peter Bläuenstein

Since Specialization
Citations

This map shows the geographic impact of Peter Bläuenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bläuenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bläuenstein more than expected).

Fields of papers citing papers by Peter Bläuenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bläuenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bläuenstein. The network helps show where Peter Bläuenstein may publish in the future.

Co-authorship network of co-authors of Peter Bläuenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bläuenstein. A scholar is included among the top collaborators of Peter Bläuenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bläuenstein. Peter Bläuenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baldoni, Daniela, Robert Waibel, Peter Bläuenstein, et al.. (2015). Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection Model. Molecular Imaging and Biology. 17(6). 829–837. 14 indexed citations
2.
Sah, Bert-Ram, Roger Schibli, Robert Waibel, et al.. (2013). Tumor Imaging in Patients with Advanced Tumors Using a New 99mTc-Radiolabeled Vitamin B12 Derivative. Journal of Nuclear Medicine. 55(1). 43–49. 27 indexed citations
3.
Müller, Cristina, Elisa Garcı́a Garayoa, Peter Bläuenstein, et al.. (2012). PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues. EJNMMI Research. 2(1). 24–24. 16 indexed citations
4.
Brans, Luc, Véronique Maes, Elisa García‐Garayoa, et al.. (2008). Glycation Methods for Bombesin Analogs Containing the (NαHis)Ac chelator for 99mTc(CO)3 Radiolabeling. Chemical Biology & Drug Design. 72(6). 496–506. 13 indexed citations
5.
García‐Garayoa, Elisa, Peter Bläuenstein, Alain Blanc, et al.. (2008). A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours. European Journal of Nuclear Medicine and Molecular Imaging. 36(1). 37–47. 51 indexed citations
6.
Treyer, Valérie, Johannes Streffer, Simon M. Ametamey, et al.. (2007). Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers. European Journal of Nuclear Medicine and Molecular Imaging. 35(4). 766–770. 26 indexed citations
7.
García‐Garayoa, Elisa, Véronique Maes, Peter Bläuenstein, et al.. (2006). Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors. Nuclear Medicine and Biology. 33(4). 495–503. 40 indexed citations
8.
Bläuenstein, Peter, Elisa Garcı́a Garayoa, Alain Blanc, et al.. (2004). Improving the Tumor Uptake of 99m Tc-Labeled Neuropeptides Using Stabilized Peptide Analogues. Cancer Biotherapy and Radiopharmaceuticals. 19(2). 181–188. 22 indexed citations
9.
Buchegger, Franz, Marek Kosinski, John O. Prior, et al.. (2003). Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients.. PubMed. 44(10). 1649–54. 80 indexed citations
10.
García‐Garayoa, Elisa, et al.. (2002). In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors. Nuclear Medicine and Biology. 29(5). 553–560. 81 indexed citations
11.
Roelcke, Ulrich, Peter Vontobel, N. E. A. Crompton, et al.. (2001). [76Br]Bromodeoxyuridine PET in tumor-bearing animals. Nuclear Medicine and Biology. 28(1). 51–57. 19 indexed citations
12.
García‐Garayoa, Elisa, et al.. (2001). In vitro and in vivo evaluation of new radiolabeled neurotensin(8–13) analogues with high affinity for NT1 receptors. Nuclear Medicine and Biology. 28(1). 75–84. 80 indexed citations
13.
Ametamey, Simon M., Peter Bläuenstein, Serge Bischoff, et al.. (2000). Synthesis, radiolabelling and biological characterization of (d)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors. Bioorganic & Medicinal Chemistry Letters. 10(1). 75–78. 9 indexed citations
14.
Huch, R., et al.. (1999). Non-invasive assessment of tumour cell proliferation with positron emission tomography and [76Br]bromodeoxyuridine. Melanoma Research. 9(6). 569–574. 12 indexed citations
15.
Bläuenstein, Peter, et al.. (1999). [76Br]bromodeoxyuridine, a potential tracer for the measurement of cell proliferation by positron emission tomography, in vitro and in vivo studies in mice. Nuclear Medicine and Biology. 26(6). 673–679. 30 indexed citations
16.
Bläuenstein, Peter, et al.. (1997). Reinvestigation of a physiological eluate of the 52Fe/52mMn generator. Applied Radiation and Isotopes. 48(8). 1097–1101. 4 indexed citations
17.
Zimmermann, Kurt, et al.. (1995). Development of a simple and selective separation of 67Cu from irradiated zinc for use in antibody labelling: A comparison of methods. Applied Radiation and Isotopes. 46(5). 329–336. 70 indexed citations
18.
Beer, H.‐F., et al.. (1992). Large scale preparation strategy for labelling of [123I]-SCH 23982, a dopamine D1 receptor binding agent. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 43(6). 781–787. 8 indexed citations
19.
Alberto, Roger, Peter Bläuenstein, Ilse Novak‐Hofer, A. R. Smith, & P. A. Schubiger. (1992). An improved method for the separation of 111Ag from irradiated natural palladium. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 43(7). 869–872. 23 indexed citations
20.
Chappuis, François, et al.. (1990). Early assessment of tissue viability with radioiodinated heptadecanoic acid in reperfused canine myocardium: Comparison with thallium-201. American Heart Journal. 119(4). 833–841. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gary L. Sieckman Breakdown of academic impact, for papers by Karen E. Linder Breakdown of academic impact, for papers by Luigi Aloj Breakdown of academic impact, for papers by Adrian D. Nunn Breakdown of academic impact, for papers by Charles J. Smith Breakdown of academic impact, for papers by Anastasia Nikolopoulou Breakdown of academic impact, for papers by Frank Roesch Breakdown of academic impact, for papers by Alexandra D. Varvarigou Breakdown of academic impact, for papers by Tammy L. Rold Breakdown of academic impact, for papers by Peter Roselt
Rankless by CCL
2026